PATENT CLAIM ANALYSIS

Application Number: 15866293
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "413000"]

Abstract:
The invention provides a unit dosage form of Ketorolac providing for a reduced dosage than typically provided to a subject in need of same, wherein said dosage form of Ketorolac is in a sterile fluid composition formulated for continuous subcutaneous delivery via body-worn infusion pump assembly, and wherein said Ketorolac is present at a concentration of between 40 mg/mL and 240 mg/mL formulated for single use delivery in a volume not to exceed 1-10 mL. Methods of use of same, body-worn infusion pump assemblies containing same and containers containing same for incorporation within a body-worn infusion pump assembly for a dose-sparing formulation comprising Ketorolac are also provided.

Claim (Index 12):
The method of  claim 1 , wherein said subject is administered Ketorolac over a period of time of more than 5 consecutive days.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.77778
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15528452', '15211560', '14550279', '13445526', '14627879']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7107729757961059
- 35 USC 102 Novelty (BERT): 0.5129751608175489
- Combined Prediction Score: 0.6909931942982502
- Mean Citation Score: 221.797032
- Max Citation Score: 259.38202
- Similarity Product: 170.34829737494232

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test